Urological Research

, Volume 13, Issue 4, pp 161–168 | Cite as

Acute oral alkali citrate load in healthy humans — Response of blood and urinary citrate, mineral metabolism, and factors related to stone formation

  • P. O. Schwille
  • J. H. Weippert
  • W. Bausch
  • G. Rümenapf
Originals
Accepted:

Summary

In ten healthy volunteers (♂/♀=5/5) the effects of two doses (2.5 and 5.0 g) of orally ingested alkali citrate (AC) on serum citrate, variables of mineral metabolism in serum, the urinary excretion of citrate, sodium and minerals were studied and compared with the effects of an oral vehicle load. Also, phosphate crystalluria and the supersaturation of several stone forming phases in urine were evaluated under all loads. The data allow to conclude that 1) the rise in serum citrate may result from citrate absorbed intestinally under AC;2) systemic metabolic alkalosis is not detectable with the chosen AC doses but may be reflected by the more alkaline urinary pH and a higher citrate excretion; 3) mineral metabolism, serum ionized calcium, parathormone, calcitonin and urinary cyclic AMP included, are more or less stable under acute loads of AC;4) postprandial phosphate crystalluria is more pronounced with increasing AC, but despite this the direct correlation with the supersaturation of hydroxyapatite is progressively weakened with both doses AC suggesting that the inhibitory effects of this drug may dominate over its effects upon initiation of precipitation.

Key words

Alkali citrate Phosphate crystalluria Supersaturation Systemic metabolic alkalosis 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbott TR (1983) Changes in serum calcium fractions and citrate concentrations during massive blood transfusions and cardiopulmonary bypass. Br J Anaesth 55:753–760Google Scholar
  2. 2.
    Ahlstrand C, Tiselius HG, Larsson L (1984) Studies on crystalluria in calcium oxalate stone formers. Urol Res 12:103–106Google Scholar
  3. 3.
    Ardaillou R (1975) Kidney and calcitonin. Nephron 15:250–260Google Scholar
  4. 4.
    Bisatz S, Felix R, Neuman WF, Fleisch H (1978) Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min Electr Metab 1:74–83Google Scholar
  5. 5.
    Brecevic L, Füredi-Mihofer H (1979) Precipitation of calcium phosphates from electrolyte solutions. V. The influence of citrate ions. Calcif Tissue Int 28:131–136Google Scholar
  6. 6.
    Butz M (1982) Oxalatsteinprophylaxe durch Alkali-Therapie. Urologe A 21:142–146Google Scholar
  7. 7.
    Chaney AL, Marbach EP (1962) Modified reagents for the determination of urea and ammonium. Clin Chem 8:130–132Google Scholar
  8. 8.
    Cheung CP, Suhadolnik RJ (1977) Analysis of inorganic pyrophosphate at the picomole level. Analyt Biochem 83:61–63Google Scholar
  9. 9.
    Dietrich FM, Hunzicker WH, Fischer JA (1975) Synthetic human calcitonin. Analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera. Acta Endocrinol 80:463–474Google Scholar
  10. 10.
    Finlayson B (1977) Calcium stones: Some physical and clinical aspects. In: Davis DS (ed) Calcium metabolism in renal failure and nephrolithiasis, Wiley and Sons, New York, pp 337–382Google Scholar
  11. 11.
    Heath III H, Body JJ, Tiegs RD, Riggs BL, Wahner H (1984) Estimates of circulating monomeric calcitonin in man. In: Pecile A (ed) Calcitonin, Chemistry Physiology, Pharmacology and Clinical Aspects, Universita degli Studi di Milano, Suppl 34Google Scholar
  12. 12.
    Hodgkinson A, Knowles CF (1976) Laboratory methods. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Clinical physiology and diagnostic procedures. Churchill Livingstone, Edinburgh London New York, p 537Google Scholar
  13. 13.
    Manoharan M, Sörgel F, Schwille PO (1985) Measurement of urinary oxalate by anion chromatography — a preliminary report. Fortschr Urol Nephrol (in press)Google Scholar
  14. 14.
    Massry SG, Coburn JW, Chapman LW, Kleeman CR (1968) Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances. Am J Physiol 214:1403–1409Google Scholar
  15. 15.
    Meyer JL, Selinger AH (1980) Effect of citrate on calcium phosphate phase transitions. Min Electr Metab 3:207–216Google Scholar
  16. 16.
    Moellering H, Gruber W (1966) Determination of citrate by citrate lyase. Analyt Biochem 17:369–376Google Scholar
  17. 17.
    Nancollas HG, Salimi MH, de Rooij JF (1984) Aspects of calcium phosphate crystallization under urinary conditions. Fortschr Urol Nephrol 22:198–206Google Scholar
  18. 18.
    Neuman WF, Neuma MW Solubilities. In: Bay EB, Coggeshall LT, de Bruyn PPH, Dragstedt LR, Park T, Taliferro WH (eds) The chemical dynamics of bone mineral. The University of Chicago Press, Chicago 37, pp 27–38Google Scholar
  19. 19.
    Pak CYC, Holt K, Britton F, Peterson R, Crowther C, Ward D (1980) Assessment of pathogenetic roles of uric acid, monopotassium urate, mono-ammonium urate and mono-sodium urate in hyperuricosuric calcium oxalate nephrolithiasis. Min Electr Metab 4:130–136Google Scholar
  20. 20.
    Ploss G, Schwille PO, Sigel A (1985) Urine and serum potassium in patients with recurrent calcium urolithiasis — Results of a pilot study. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, pp 343–346Google Scholar
  21. 21.
    Rudman D, Dedonis JL, Fountain MT, Chandler JB, Gerron GG, Fleming A, Kutner MH (1980) Hypocitraturia in patients with gastrointestinal malabsorption. New Engl J Med 303: 657–661Google Scholar
  22. 22.
    Rudman D, Kutner MH, Redd SC, Water WC, Gerron GG, Bleier J (1982) Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab 55:1052–1057Google Scholar
  23. 23.
    Sakhaee K, Nicar M, Hill K, Pak CYC (1983) Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone forming salts. Kidney Int 24:348–352Google Scholar
  24. 24.
    Schwille PO (1979) Bestimmung von Parathormon. In: Koch H, Domschke W (eds) Diagnostik in der Gastroenterologie. Thieme, StuttgartGoogle Scholar
  25. 25.
    Schwille PO, Scholz D, Schwille K, Leutschaft R, Goldberg I, Sigel A (1982) Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinie. Nephron 31:194–202Google Scholar
  26. 26.
    Schwille PO, Scholz D, Schwille K (1982) Ultrafiltrable citrate and the relationship between serum and urinary citrate. Results in controls and stone formers. J Clin Chem Clin Biochem 20:169–173Google Scholar
  27. 27.
    Schwille PO, Hanisch E, Scholz D (1984) Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. J Urol 132:650–655Google Scholar
  28. 28.
    Schwille PO, Wölfel G, Goldberg I, Bausch W, Bernreuther K, Rümenapf G, Sigel A (1985) Some stone promoting and inhibiting factors in fasting and postprandial urine of stone patients and control — preliminary results. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum, Press, New York London, pp 335–338Google Scholar
  29. 29.
    Simpson DP (1983) Citrate excretion: A window on renal metabolism. Am J Physiol 244:F223-F234Google Scholar
  30. 30.
    Smith LH, Meyer JL, McCall JT (1973) Chemical nature of crystal inhibitors isolated from human urine. In: Cifuentes Delatte L, Rapado A, Hodginson A (eds) Urinary calculi. Recent advances in aetiology, stone structure and treatment. Karger, Basel, pp 318–327Google Scholar
  31. 31.
    Smith LH, Werness PG, Erickson SD, Phillips SF (1984) Postprandial response to a normal diet in patients with idiopathic calcium urolithiasis. In: Ryall RL, Brockis JG, Marshall VR, Finlayson B (eds) Urinary stone. Churchill Livingstone. Melbourne Edinburgh London New York, pp 47–56Google Scholar
  32. 32.
    Sutton RAL, Wong NLM, Dirks JH (1979) Effect of metabolic acidosis and alkalosis on sodium and calcium transport in the dog kidney. Kidney Int 15:520–533Google Scholar
  33. 33.
    Swaroop S (1973) A micromethod for the determination of urinary inorganic sulfate. Clin Chim Acta 46:333–337Google Scholar
  34. 34.
    Tiselius HG (1984) Urinary pH and calcium oxalate crystallization. Fortschr Urol Nephrol 22:184–187Google Scholar
  35. 35.
    Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181Google Scholar
  36. 36.
    Werness PG, Wilson JWL, Smith LH (1984) Hydroxyapatite and its roles in calcium urolithiasis. In: Ryall R, Brockis JG, Marshall V, Finlayson B (eds) Urinary stone, Churchill Livingstone, Melbourne Edinburgh London New York, pp 273–277Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • P. O. Schwille
    • 1
    • 2
    • 3
    • 5
  • J. H. Weippert
    • 1
    • 2
    • 3
  • W. Bausch
    • 4
  • G. Rümenapf
    • 1
    • 2
    • 3
  1. 1.Mineral Metabolism and Endocrine Research LaboratoryUniversity of ErlangenErlangenFederal Republic of Germany
  2. 2.Department of SurgeryUniversity of ErlangenErlangenFederal Republic of Germany
  3. 3.Department of UrologyUniversity of ErlangenErlangenFederal Republic of Germany
  4. 4.Department of MineralogyUniversity of ErlangenErlangenFederal Republic of Germany
  5. 5.University HospitalErlangen

Personalised recommendations